Teacher tried to dissuade Nobel winner Gurdon from science
Veteran British scientist John Gurdon, who shared the Nobel Prize for medicine on Monday, is often described as the "godfather of cloning" for his work on stem cell research but was once told by his teacher not to pursue a career in science.
Based at Cambridge University, Gurdon shared the prize with Shinya Yamanaka of Japan for work on reprogramming cells, which offers hope to people whose lives are blighted by disease.
The pioneering research helped clear the way for further work on cell programming.
Gurdon is fond of recalling that when he was 15, a tutor wrote in his school report that it would be a "total waste of time" if he followed a career in biology "and this whole idea should be immediately discouraged".
He has said he keeps the report above his desk "for my amusement".
His mother though had spotted that he was fascinated by the subject.
"Even at school I used to grow thousands of caterpillars to make moths, to the intense annoyance of my tutor," Gurdon said in an interview several years ago.
"But I had a fascination for these things, and I think it was really she particularly who enabled me to switch from my education, which was completely non-scientific, into a scientific direction."
When it came to choose a career his father wanted him to go into the army or banking.
"Fortunately for me, I was refused entry to the army for the national service, a piece of good luck," he recalled.
"I was actually a competitive squash player at the time and rather fit, but the family doctor decided I was not suitable for the army and diagnosed my slight cold as bronchitis, and that eliminated any possibility, thank heavens, of entering the army as a career," he said.
He managed to win a place at Oxford University. His first intention had been to study classics but the admissions tutor said he would grant him a place providing it was not in that subject.
His post-doctorate thesis was on nuclear transplantation, the subject that has obsessed him throughout his career.
In 1971, he moved to Oxford's great rival, Cambridge, and in 1989 Gurdon started the prestigious Wellcome/CRC institute at the university.
(c) 2012 AFP
- I did my best work 50 years ago, says Nobel winner Gurdon (Update) Oct 08, 2012 | not rated yet | 0
- Obesity or stem cell research could win Nobel Oct 02, 2011 | not rated yet | 0
- Awards given for leukemia treatment, DNA advances Sep 14, 2009 | not rated yet | 0
- Nobel prize to Briton, Japanese for stem cell work (Update 4) Oct 08, 2012 | not rated yet | 0
- New route to leukemia uncovered Sep 28, 2009 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011 I'd like to open a discussion thread for version 2 of the draft of my book ''Classical and Quantum Mechanics via Lie algebras'', available online at http://lanl.arxiv.org/abs/0810.1019 , and for the...
- More from Physics Forums - Independent Research
More news stories
Early use of tracheostomy for mechanically ventilated patients not associated with improved survival
For critically ill patients receiving mechanical ventilation, early tracheostomy (within the first 4 days after admission) was not associated with an improvement in the risk of death within 30 days compared to patients who ...
Other 3 hours ago | not rated yet | 0
The decision to limit life support in patients in the intensive care unit (ICU) appears to be significantly influenced by physician practices and/or the culture of the hospital, suggests new findings from researchers at the ...
Other 5 hours ago | not rated yet | 0
Knee replacement surgery is a very common procedure. However, it does not always resolve function or pain in all the recipients of new knees. A study by Robert Barrack, MD and his colleagues from the Washington University ...
Other 7 hours ago | not rated yet | 0
Doctors are trained to think "common disease" when they meet patients in their practices, and as they rarely or never meet a rare disease, it often takes many years to reach the right diagnosis. A new search tool called FindZebra ...
Other 8 hours ago | not rated yet | 0
Delayed transfer to the intensive care unit (ICU) in hospitalized patients significantly increases the risk of dying in the hospital, according to a new study from researchers in Chicago.
Other 9 hours ago | not rated yet | 0
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
1 hour ago | 5 / 5 (1) | 0
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
8 hours ago | 4 / 5 (4) | 0 |
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
2 hours ago | 5 / 5 (3) | 0 |
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
6 hours ago | 4.8 / 5 (6) | 0 |
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
3 hours ago | not rated yet | 0 |
By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...
2 hours ago | not rated yet | 0